vs
Mission Produce, Inc.（AVO）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
Mission Produce, Inc.的季度营收约是REPLIGEN CORP的1.6倍（$319.0M vs $197.9M），REPLIGEN CORP净利率更高（6.7% vs 5.0%，领先1.7%），REPLIGEN CORP同比增速更快（13.6% vs -10.0%），Mission Produce, Inc.自由现金流更多（$55.6M vs $17.6M），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs 11.0%）
根据现有信息，该描述将Mission Produce, Inc.错误混淆为一家日本电子游戏企业。原描述提及这家企业由前IREM员工于1990年4月6日创立，曾为艾尼克斯、哈德森开发多款游戏，作品覆盖街机、超级任天堂、Nintendo 64、PlayStation等多个平台。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
AVO vs RGEN — 直观对比
营收规模更大
AVO
是对方的1.6倍
$197.9M
营收增速更快
RGEN
高出23.6%
-10.0%
净利率更高
RGEN
高出1.7%
5.0%
自由现金流更多
AVO
多$38.0M
$17.6M
两年增速更快
RGEN
近两年复合增速
11.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $319.0M | $197.9M |
| 净利润 | $16.0M | $13.3M |
| 毛利率 | 17.5% | 52.5% |
| 营业利润率 | 8.8% | 9.0% |
| 净利率 | 5.0% | 6.7% |
| 营收同比 | -10.0% | 13.6% |
| 净利润同比 | -7.5% | 143.9% |
| 每股收益（稀释后） | $0.23 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AVORGEN
| Q4 25 | $319.0M | $197.9M | ||
| Q3 25 | $357.7M | $188.8M | ||
| Q2 25 | $380.3M | $182.4M | ||
| Q1 25 | $334.2M | $169.2M | ||
| Q4 24 | $354.4M | $174.1M | ||
| Q3 24 | $324.0M | $154.9M | ||
| Q2 24 | $297.6M | $154.1M | ||
| Q1 24 | $258.7M | $151.3M |
净利润AVORGEN
| Q4 25 | $16.0M | $13.3M | ||
| Q3 25 | $14.7M | $14.9M | ||
| Q2 25 | $3.1M | $14.9M | ||
| Q1 25 | $3.9M | $5.8M | ||
| Q4 24 | $17.3M | $-30.3M | ||
| Q3 24 | $12.4M | $-654.0K | ||
| Q2 24 | $7.0M | $3.3M | ||
| Q1 24 | $0 | $2.1M |
毛利率AVORGEN
| Q4 25 | 17.5% | 52.5% | ||
| Q3 25 | 12.6% | 53.2% | ||
| Q2 25 | 7.5% | 50.0% | ||
| Q1 25 | 9.4% | 53.6% | ||
| Q4 24 | 15.7% | 26.1% | ||
| Q3 24 | 11.4% | 50.0% | ||
| Q2 24 | 10.4% | 49.8% | ||
| Q1 24 | 11.1% | 49.5% |
营业利润率AVORGEN
| Q4 25 | 8.8% | 9.0% | ||
| Q3 25 | 5.9% | 8.9% | ||
| Q2 25 | 1.8% | 7.6% | ||
| Q1 25 | 2.8% | 3.9% | ||
| Q4 24 | 8.1% | -17.7% | ||
| Q3 24 | 5.2% | -5.1% | ||
| Q2 24 | 4.1% | 1.0% | ||
| Q1 24 | 3.1% | 1.3% |
净利率AVORGEN
| Q4 25 | 5.0% | 6.7% | ||
| Q3 25 | 4.1% | 7.9% | ||
| Q2 25 | 0.8% | 8.2% | ||
| Q1 25 | 1.2% | 3.4% | ||
| Q4 24 | 4.9% | -17.4% | ||
| Q3 24 | 3.8% | -0.4% | ||
| Q2 24 | 2.4% | 2.2% | ||
| Q1 24 | — | 1.4% |
每股收益（稀释后）AVORGEN
| Q4 25 | $0.23 | $0.24 | ||
| Q3 25 | $0.21 | $0.26 | ||
| Q2 25 | $0.04 | $0.26 | ||
| Q1 25 | $0.05 | $0.10 | ||
| Q4 24 | $0.25 | $-0.55 | ||
| Q3 24 | $0.17 | $-0.01 | ||
| Q2 24 | $0.10 | $0.06 | ||
| Q1 24 | $0.00 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $64.8M | $767.6M |
| 总债务越低越好 | $95.8M | $542.2M |
| 股东权益账面价值 | $587.3M | $2.1B |
| 总资产 | $983.0M | $2.9B |
| 负债/权益比越低杠杆越低 | 0.16× | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资AVORGEN
| Q4 25 | $64.8M | $767.6M | ||
| Q3 25 | $43.7M | $748.7M | ||
| Q2 25 | $36.7M | $708.9M | ||
| Q1 25 | $40.1M | $697.2M | ||
| Q4 24 | $58.0M | $757.4M | ||
| Q3 24 | $49.5M | $784.0M | ||
| Q2 24 | $46.2M | $809.1M | ||
| Q1 24 | $39.9M | $780.6M |
总债务AVORGEN
| Q4 25 | $95.8M | $542.2M | ||
| Q3 25 | $131.5M | $537.9M | ||
| Q2 25 | $147.2M | — | ||
| Q1 25 | $117.9M | — | ||
| Q4 24 | $113.7M | $525.6M | ||
| Q3 24 | $134.4M | — | ||
| Q2 24 | $170.2M | — | ||
| Q1 24 | $156.1M | — |
股东权益AVORGEN
| Q4 25 | $587.3M | $2.1B | ||
| Q3 25 | $568.7M | $2.1B | ||
| Q2 25 | $552.3M | $2.1B | ||
| Q1 25 | $550.8M | $2.0B | ||
| Q4 24 | $547.3M | $2.0B | ||
| Q3 24 | $527.3M | $2.0B | ||
| Q2 24 | $513.3M | $2.0B | ||
| Q1 24 | $505.1M | $2.0B |
总资产AVORGEN
| Q4 25 | $983.0M | $2.9B | ||
| Q3 25 | $1.0B | $2.9B | ||
| Q2 25 | $1.0B | $2.9B | ||
| Q1 25 | $997.8M | $2.9B | ||
| Q4 24 | $971.5M | $2.8B | ||
| Q3 24 | $959.9M | $2.8B | ||
| Q2 24 | $966.9M | $2.9B | ||
| Q1 24 | $937.5M | $2.8B |
负债/权益比AVORGEN
| Q4 25 | 0.16× | 0.26× | ||
| Q3 25 | 0.23× | 0.26× | ||
| Q2 25 | 0.27× | — | ||
| Q1 25 | 0.21× | — | ||
| Q4 24 | 0.21× | 0.27× | ||
| Q3 24 | 0.25× | — | ||
| Q2 24 | 0.33× | — | ||
| Q1 24 | 0.31× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $67.2M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $55.6M | $17.6M |
| 自由现金流率自由现金流/营收 | 17.4% | 8.9% |
| 资本支出强度资本支出/营收 | 3.6% | 4.1% |
| 现金转化率经营现金流/净利润 | 4.20× | 1.93× |
| 过去12个月自由现金流最近4个季度 | $37.2M | $93.9M |
8季度趋势，按日历期对齐
经营现金流AVORGEN
| Q4 25 | $67.2M | $25.7M | ||
| Q3 25 | $34.4M | $48.1M | ||
| Q2 25 | $-11.8M | $28.6M | ||
| Q1 25 | $-1.2M | $15.0M | ||
| Q4 24 | $38.0M | $39.2M | ||
| Q3 24 | $42.5M | $49.3M | ||
| Q2 24 | $3.4M | $42.2M | ||
| Q1 24 | $9.5M | $44.7M |
自由现金流AVORGEN
| Q4 25 | $55.6M | $17.6M | ||
| Q3 25 | $22.6M | $43.4M | ||
| Q2 25 | $-25.0M | $21.5M | ||
| Q1 25 | $-16.0M | $11.4M | ||
| Q4 24 | $31.1M | $33.6M | ||
| Q3 24 | $34.9M | $42.3M | ||
| Q2 24 | $-4.4M | $37.4M | ||
| Q1 24 | $-400.0K | $36.4M |
自由现金流率AVORGEN
| Q4 25 | 17.4% | 8.9% | ||
| Q3 25 | 6.3% | 23.0% | ||
| Q2 25 | -6.6% | 11.8% | ||
| Q1 25 | -4.8% | 6.8% | ||
| Q4 24 | 8.8% | 19.3% | ||
| Q3 24 | 10.8% | 27.3% | ||
| Q2 24 | -1.5% | 24.3% | ||
| Q1 24 | -0.2% | 24.0% |
资本支出强度AVORGEN
| Q4 25 | 3.6% | 4.1% | ||
| Q3 25 | 3.3% | 2.5% | ||
| Q2 25 | 3.5% | 3.9% | ||
| Q1 25 | 4.4% | 2.1% | ||
| Q4 24 | 1.9% | 3.2% | ||
| Q3 24 | 2.3% | 4.5% | ||
| Q2 24 | 2.6% | 3.1% | ||
| Q1 24 | 3.8% | 5.5% |
现金转化率AVORGEN
| Q4 25 | 4.20× | 1.93× | ||
| Q3 25 | 2.34× | 3.23× | ||
| Q2 25 | -3.81× | 1.92× | ||
| Q1 25 | -0.31× | 2.57× | ||
| Q4 24 | 2.20× | — | ||
| Q3 24 | 3.43× | — | ||
| Q2 24 | 0.49× | 12.70× | ||
| Q1 24 | — | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AVO
| Avocado | $256.9M | 81% |
| Blueberry | $36.5M | 11% |
| Mango | $18.7M | 6% |
| Other | $6.9M | 2% |
RGEN
暂无分部数据
